| [1] |
Khuroo MS, Khuroo MS, Khuroo NS. Hepatitis E: discovery, global impact, control and cure[J]. World J Gastroenterol,2016,22(31):7030- 7045.
|
| [2] |
WHO. Hepatitis E fact sheet[EB/OL]. 2017.
URL
|
| [3] |
Ren X, Wu P, Wang LP, et al. Changing epidemiology of hepatitis A and hepatitis E viruses in China,1990-2014[J]. Emerg Infect Dis,2017,23(2):276-277.
|
| [4] |
Jin H, Zhao Y, Zhang X, et al. Case-fatality risk of pregnant women with acute viral hepatitis type E: A systematic review and meta-analysis[J]. Epidemiol Infect,2016,144(10):2098-2106.
|
| [5] |
ICTV. Virus Taxonomy: 2015 release[EB/OL]. 2017.
URL
|
| [6] |
Sridhar S, Teng JLL, Chiu TH, et al. Hepatitis E virus genotypes and evolution: emergence of camel hepatitis E variants[J]. Int J Mol Sci,2017,18(4):869.
|
| [7] |
Rasche A, Saqib M, Liljander AM, et al. Hepatitis E virus infection in dromedaries, North and East Africa, United Arab Emirates, and Pakistan, 1983-2015[J]. Emerg Infect Dis,2016,22(7):1249-1252.
|
| [8] |
Debing Y, Moradpour D, Neyts J, et al. Update on hepatitis E virology: implications for clinical practice[J]. J Hepatol,2016,65(1):200-212.
|
| [9] |
Hartl J, Otto B, Madden RG, et al. Hepatitis E seroprevalence in Europe: a meta-analysis[J]. Viruses,2016,8(8):211.
|
| [10] |
Nair VP, Anang S, Subramani C, et al. Endoplasmic reticulum stress induced synthesis of a novel viral factor mediate sufficient replication of genotype-1 hepatitis E virus[J]. PLoS Pathog,2016,12(4):e1005521.
|
| [11] |
Huang F, Li Y, Yu W, et al. Excretion of infectious hepatitis E virus into milk in cows imposes high risks of zoonosis[J]. Hepatology,2016,64(2):350-359.
|
| [12] |
Khuroo MS, Khuroo MS, Khuroo NS. Transmission of hepatitis E virus in developing countries[J]. Viruses,2016,8(9):253.
|
| [13] |
Cui W, Sun Y, Xu A, et al. Hepatitis E seroprevalence and related risk factors among seafood processing workers: A cross-sectional survey in Shandong Province, China[J]. Int J Infect Dis,2016,49:62-66.
|
| [14] |
Yin X, Ambardekar C, Lu Y, et al. Distinct entry mechanisms for non-enveloped and quasi-envelop hepatitis E virus[J]. J Virol,2016,90(8):4232-4242.
|
| [15] |
Allweiss L, Gass S, Giersch K, et al. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation[J]. J Hepatol,2016,64(5):1033-1040.
|
| [16] |
Van de Garde, Pas SD, van der Net, et al. Hepatitis E virus (HEV) genotype 3 infection of human liver chimericmiceas a model for chronic HEV infection[J]. J Virol,2016,90(9):4394-4401.
|
| [17] |
Yin X, Li XL, Feng ZD. Role of envelopment in the HEV life cycle[J]. Viruses,2016,8(8):E229.
|
| [18] |
Pischke S, Schwarze-Zander C, Bremer B, et al. Hepatitis E virus seroprevalence rate in HIV-infected patients in Germany: a comparison of two commercial assays[J]. Intervirology,2015,58(8):283-287.
|
| [19] |
O’Marion F, Abravanel S, Lhomme, et al. Hepatitis E in transplantation[J]. Cur Infect Dis Rep,2016,18(3):1-8.
|
| [20] |
Haffar S, Bazerbachi F, Garg S, et al. Frequency and prognosis of acute pancreatitis associated with acute hepatitis E: Asystematic review[J]. Pancreatology,2015,15(4):321-326.
|
| [21] |
Tejero H, Montero F, Nuno JC. Theories of lethal mutagenesis: from error catastrophe to lethal defection[J]. Curr Top Microbiol Immunol,2016,392:161-179.
|
| [22] |
Todt D, Gisa A, Radonic A, et al. In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome[J]. Gut,2016,65(10):1733-1743.
|
| [23] |
Dao Thi VL, Debing Y, Wu X, et al. Sofosbuvir inhibi the patitis E virus replicationin vitro and results in an additive effect when combined with ribavirin[J]. Gastroenterology,2016,150(1):82-85.
|
| [24] |
Nan Y, Ma Z, Kannan H, et al. Inhibition of hepatitis E virus replication by peptide-conjugated morpholino oligomers[J]. Antiviral Res,2015,120:134-139.
|
| [25] |
Smith DB, Simmonds P. Hepatitis E virus and fulminant hepatitis-a virus or host-specific pathology?[J]. Liver Int,2015,35(4):1334-1340.
|
| [26] |
Kamar N, Lhomme S, Abravanel F, et al. An early viral response predicts the virological response to ribavirin in hepatitis E virus organ transplant patients[J]. Transplantation,2015,99(10):2124-2131.
|
| [27] |
Abravanel F, Lhomme S, Rostaing L, et al. Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse[J]. Clin Infect Dis,2015,60(1):96-99.
|
| [28] |
Irshad M, Gupta P, Mankotia DS, et al. Multiplex qPCR for serodetection and serotyping ofhepatitis viruses: A brief review[J]. World J Gastroenterol,2016,22(20):4824-4834.
|
| [29] |
Wang L, Xia J, Wang L, et al. Experimental infection of rabbits with genotype 3 hepatitis E virus produced both chronicity and kidney injury[J]. Gut,2017,66(3):561-562.
|
| [30] |
Li TC, Yang T, Yoshizaki S, et al. Ferret hepatitis E virus infection induces acute hepatitis and persistent infection in ferrets[J]. Vet Microbiol,2016,183:30-36.
|
| [31] |
Yang Y, Shi R, She R, et al. Effect of swine hepatitis E virus on the livers of experimentally infected Mongolian gerbils by swine hepatitis E virus[J]. Virus Res,2015,208:171-179.
|
| [32] |
Devhare PB, Desai S, Lole KS. Innate immune responses in humanhepatocyte-derived cell lines alter genotype 1 hepatitis E virus replication efficiencies[J]. Sci Rep,2016,6:26827.
|
| [33] |
Yin X, Ambardekar C, Lu Y, et al. Distinct entry mechanisms for nonenveloped and quasi-enveloped hepatitis E viruses[J]. J Virol,2016,90(8):4232-4242.
|
| [34] |
Li SW, Zhao Q, Wu T, et al. The development of a recombinant hepatitis E vaccine HEV 239[J]. Hum Vaccin Immunother,2015,11(4):908-914.
|